Cytokine expression was also analyzed in skin-draining lymph nodes (LN; Figure 2l ). Upon MC903 treatment, the induction of Th2 cytokines (IL4, IL13, IL10, IL6, and IL31) in WT LNs was not observed in TSLP epÀ/À LNs, indicating that the MC903-triggered Th2 response is abolished in TSLP epÀ/À mice. No change was seen for IFNg transcript levels in WT or TSLP epÀ/À LNs, from either MC903-or ethanol-treated mice, suggesting that MC903 application does not involve a Th1 response in LNs.
In conclusion, we demonstrate unequivocally here that TSLP produced by keratinocytes is absolutely required in pathogenesis of AD triggered by topical application of the vitamin D3 analogue MC903. We also show that in this AD model, induction of IL4, IL13, IL31, and eotaxin-2 is fully TSLP dependent, whereas that of IL6, IL10, and monocyte chemotactic protein-2 is only partially TSLP dependent, and that of IFNg is TSLP independent. Finally, our floxed TSLP mice will be helpful for selective ablation of TSLP in other cell types (Soumelis and Liu, 2004; Ziegler and Liu, 2006; Holgate, 2007; Sokol et al., 2008) , and therefore to further elucidate the physiological and pathological function of this cytokine.
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We thank the staff of the mouse knockout, histopathology, hematology, and animal facilities of TO THE EDITOR Individuals with xeroderma pigmentosum syndrome (XP) present an extremely high sensitivity to sunlight, with increased incidence of skin cancer (especially in sun-exposed areas), when compared to the normal population. Some XP patients can also display developmental complications and early aging features. A genetic defect in the nucleotide excision repair pathway (NER) was described as the molecular cause of XP syndrome (Cleaver, 1968) , and somatic cell fusion accompanied by functional complementation using unscheduled DNA synthesis (UDS) assays led to the identification of seven complementation groups, which correspond to some of the genes involved in NER (designated XPA to XPG) (Costa et al., 2003; Lehmann, 2003) . Among these genes, mutations in XPA and XPC are the most frequent and are responsible for approximately half of all XP cases in the world (Zeng et al., 1997). All described XP mutations can be found in the XP mutations database (http://xpmutations.org).
This work describes mutations in fibroblasts obtained from three children with clinical diagnosis of XP, from two nonrelated families. All three patients were born from consanguineous marriages and manifested sunburning on minimal sun exposure, photophobia, and corneal and eye lid deformities. None of them presented neurological abnormalities. The XP02SP patient is 12 years old and displayed several cutaneous tumors in sun-exposed areas, beginning at age 7 (basal-cell carcinomas, squamous-cell carcinoma, malignant fibrohistiocytoma, and atypical in situ melanocyte proliferation). The XP03SP patient is also a 12-year old, and developed actinic keratosis and basal-cell carcinomas at the age of 8 years. Patient XP04SP, brother of patient XP03SP, died at age 13 after complications of an invasive and extremely agressive squamous-cell carcinoma that led to partial destruction of his face. This patient also had a T-cell lymphoma at the age of 3, curiously not commonly observed in XP patients, which responded to chemotherapy, although an acceleration of the progression of skin lesions was observed during treatment.
To determine XP patients' complementation group, fibroblasts from skin biopsies of patients were infected with recombinant adenovirus carrying XPA (AdyXPA) or XPC (AdXPC; Muotri et al., 2002) functional cDNA and, later, gene complementation was analyzed by UDS. For noninfected cells, UV-irradiated NER-proficient fibroblasts presented a high number of nuclear grains, whereas cells from patients exhibited reduced UDS levels, confirming their XP diagnoses. Cells infected with AdyXPA ( Figure 1a ) did not present any increase in grain number. In contrast, after the XP fibroblasts were infected with AdXPC, the levels of UDS increased to values comparable to those of NER-proficient cells (Figure 1b) .
To further confirm the complementation of DNA repair deficiency by AdXPC infection, XP and proficient DNA repair cells were irradiated with UV light, and cell survival was measured 7 days later (Figure 1c-f) . At the doses employed, UV irradiation was not able to generate a significant reduction of survival rates in DNA repair proficient cells (normal human fibroblast, FHN), regardless of previous infection with AdXPC. On the other hand, XP02SP, XP03SP, and XP04SP cells became more resistant to irradiation effects when previously infected with AdXPC. No changes in cell-survival levels were observed in cells infected with AdyXPA (data not shown).
Total RNA and genomic DNA from cell lineages of FHN, XP02SP, XP03SP, and XP04SP were extracted to identify molecular mutations in the XPC gene. Three amplification products resulted in strong and well-defined bands. The amplification of regions c.1_895 (from exon 1 to exon 6) and c.732_1549 (end of exons 5.2 to the first half of the exon 8) result in cDNA fragments with the expected sizes for all cells. However, the product of cDNA amplification for region c.1480_2249 (including the second half of exon 8 to part of exon 11), resulted in bands of the expected sizes (791 bp) for control cells, but different fragments were also observed for the cells from patients (Figure 2a) . The cDNA and genomic DNA from cells were sequenced, and the genetic alterations identified in the XPC sequence are described in Table 1 . Schematic representation of the mutation observed in one of the XP cells is shown in Figure 2b . Many of the variations correspond to polymorphisms that have already been reported (Table 1) .
DNA sequencing for XP02SP cells revealed to our knowledge a previously unreported mutation c.1969G4T (p.Glu657X) at exon 9 for the longer cDNA fragment and for genomic DNA (Figure 2b and c) and a deletion of exon 9 (c.1874_2034) present only at the smaller cDNA amplification fragment (2c). This deletion was not detected in genomic DNA and probably resulted from an mRNA splicing error. The deletion and the mutation potentially generate a truncated protein, with incomplete HR23B and DNA interaction domains and the TFIIH interaction site completely absent (Uchida et al., 2002) . Genomic sequencing revealed a c.1643-1644delTG present at exon 8 in XP03SP cells. This last mutation was confirmed by cDNA sequencing of XP04SP cells (Figure 2c ). Another mutation was also observed in the cDNA from XP04SP cells: a deletion of 245 bp of the second half of exon 8 (c.1627_1872del). The two mutations observed for the cDNA on XP03SP and XP04SP potentially generate a frameshift and truncated XPC protein that affects the sites of HR23B, TFIIH interactions, and DNA binding. The c.1643_1644delTG as well as the cDNA deletion (c.1627_1872del) were previously described for XP26PV cells obtained from Italian patients and unrelated kindreds (Chavanne et al., 2000) , although the same deletion (c.1627_1872 del) was also described as a result of alternative spliced XPC mRNA, from a cryptic splice site, not XP related (Gozukara et al., 2001) . The deletion of two bases (c.1643_1644 delTG) was proposed to originate from DNA polymerase slippage at the DNA segment containing a three repeated TG, and configures a hotspot mutation present at the XPC gene (Chavanne et al., 2000; Khan et al., 2006) . In summary, this study presents the use of recombinant adenovirus carrying XP genes as an efficient tool for diagnosis of XP patients' complementation groups and confirms the molecular characterization of two mutations of the XPC gene obtained from Brazilian XP patients, adding to our knowledge a previously unreported mutation causing this syndrome. Besides XPA and XPC genes, recombinant adenovirus carrying XPD and XPV genes are also available for complementation analysis (Armelini et al., 2005; Lima-Bessa et al., 2006) . We propose the use of these recombinant viruses as an alternative to the other Figure S1 and genomic and cDNA primers are presented in Table S1 .
methods used for XP complementation diagnostics, such as somatic cell fusion (Cleaver et al., 1975) and gene reporter after plasmid transfection assays (Carreau et al., 1995; Khan et al., 1998) . Table S1 . Sequence of the primers used in this work (XPC DNA genomic sequence reference: gi|37550163:14126000-14162000). GenBank accession numbers: EU530520-530534. These are variations observed in the introns, which have not been described before, although we have found few (two and three) similar sequences at NCBI database. Note that the mutation c.2253+43G4C is observed in both normal and XP02SP cells. These polymorphisms were previously reported in the NCBI single-nucleotide polymorphisms site (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi? locusId=7508): rs2228000; rs2227998; rs3731151.
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